Latest Corticosteroids Stories
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate(®)
Novel formulation, dosed twice daily, shows superiority to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery in Phase 3 study If approved, sub-micron
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.